NARAMIG

This brand name is authorized in Australia, Brazil, Germany, Estonia, Spain, Finland, France, Israel, Lithuania, Netherlands, Poland, Singapore, United Kingdom, South Africa

Active ingredients

The drug NARAMIG contains one active pharmaceutical ingredient (API):

1 Naratriptan
UNII 10X8X4P12Z - NARATRIPTAN HYDROCHLORIDE

Naratriptan has been shown to be a selective agonist for 5 hydroxytryptamine1 (5-HT1) receptors mediating vascular contraction. This receptor is found predominantly in intracranial (cerebral and dural) blood vessels. Naratriptan is indicated for the acute treatment of migraine attacks with or without aura.

Read about Naratriptan

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
NARAMIG Tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
N02CC02 Naratriptan N Nervous system → N02 Analgesics → N02C Antimigraine preparations → N02CC Selective serotonin (5HT1) agonists
Discover more medicines within N02CC02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: AU Pharmaceutical Benefits Scheme Identifier(s): 8298R, 9734H
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 510605201111316, 510614050051703
Country: DE Bundesinstitut für Arzneimittel und Medizinprodukte Identifier(s): 02465536, 08608801
Country: EE Ravimiamet Identifier(s): 1036459, 1076790, 1076802
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 61828
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 489963
Country: FR Base de données publique des médicaments Identifier(s): 67586588
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 139356, 143217, 143218, 143219, 20113, 373616
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 8161
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1003095
Country: NL Z-Index G-Standaard, PRK Identifier(s): 48534
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100123308
Country: SG Health Sciences Authority Identifier(s): 09914P
Country: ZA Health Products Regulatory Authority Identifier(s): 32/7.3/0463

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.